title: Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation.
authors.forename: J L
authors.initials: JL
authors.lastname: Wagner
authors.forename: M E
authors.initials: ME
authors.lastname: Flowers
authors.forename: G
authors.initials: G
authors.lastname: Longton
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: P
authors.initials: P
authors.lastname: Martin
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood; D001706:Biopsy; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002908:Chronic Disease; D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D007074:Immunoglobulin G / Q000097:blood; D008046:Lip / Q000473:pathology; D009061:Mouth Mucosa / Q000473:pathology; D015999:Multivariate Analysis; D010808:Physical Examination; D010976:Platelet Count; D011237:Predictive Value of Tests; D012306:Risk; D012867:Skin / Q000473:pathology; D016019:Survival Analysis; D013997:Time Factors; D014985:Xerophthalmia / Q000175:diagnosis / Q000209:etiology
chemical_list: D007074:Immunoglobulin G; D000469:Alkaline Phosphatase